‌

US Patent 7575886 Analysis of sulfated polysaccharides

Patent 7575886 was granted and assigned to Momenta Pharmaceuticals on August, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Current Assignee

Momenta Pharmaceuticals

Date Filed

March 11, 2003

Date of Patent

August 18, 2009

Patent Application Number

10386402

Patent Citations Received

US Patent 12128109 Muscle targeting complexes and formulations for treating dystrophinopathies

0

US Patent 12012460 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

0

US Patent 12018087 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject

0

US Patent 12102687 Muscle targeting complexes and uses thereof for treating myotonic dystrophy

0

US Patent 11672872 Anti-transferrin receptor antibody and uses thereof

0

US Patent 11679161 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

0

US Patent 11759525 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

US Patent 11771776 Muscle targeting complexes and uses thereof for treating dystrophinopathies

US Patent 11787869 Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness

US Patent 11833217 Muscle targeting complexes and uses thereof for treating dystrophinopathies

0

•••

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Primary Examiner

Find more entities like US Patent 7575886 Analysis of sulfated polysaccharides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.